24小时热门版块排行榜    

查看: 2739  |  回复: 8
当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖

xuezhaoteng

金虫 (正式写手)

[交流] 文章回来,请大侠帮忙看看 已有6人参与

This paper uses fluorescently labelled DNA attached to streptavidin-coated magnetic beads to detect the presence of a biotinylated antibody on a surface.  There's really no reason to use DNA, any fluorescently labelled biotinylated molecule would do fine.  Also, the antigen is non-specifically adsorbed to the surface; a second antibody would result in a true ELISA antibody sandwich assay.  Only one antigen is used;  the specificity of the antigen-Ab binding is not confirmed.
这是什么意思啊?
回复此楼

» 猜你喜欢

» 本主题相关价值贴推荐,对您同样有帮助:

已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

yw__577

金虫 (文坛精英)

xuezhaoteng(金币+1): 2010-09-06 16:26:13
这个主编很认真,对审稿人的看法还有个总结,这个较少见,楼主当认真修改,希望还是有的
5楼2010-06-28 16:43:08
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 9 个回答

nandi2212

新虫 (知名作家)

xuezhaoteng(金币+1): 2010-09-06 16:26:33
楼主究竟哪句话看不懂??要说具体点!我不相信你一句都不懂,呵呵
2楼2010-06-28 16:24:14
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

xuezhaoteng

金虫 (正式写手)

Dear xx:

The above referenced manuscript has been reviewed by three experts in the field. Reviewer #2 recommends major revision for prior to acceptance, while Reviewers #1 and #3 feel the manuscript is premature at the present stage. I think Reviewer #1 misunderstands the concept of the quantitative assay. I believe the quantitative measurements are made by the number of bright spots, not by brightness of each spot. However, Reviewer #1 does not highly appreciate the study. In light of these comments, we are unable to consider the manuscript further for publication in its present form. We would be willing, however, to consider a substantially revised manuscript that addresses these concerns. Please include a detailed cover letter that addresses each of the comments. Please pay special attention to some of the Reviewer’s comments as described below.  Reviewer #3 raises very serious concerns concerning the concept of the study.  The reviews are enclosed with this letter.

(1) It is very essential to answer Reviewer #3’s concerns in a reasonable manner.
(2)It is preferable to add in the text more comprehensive explanation concerning the quantitative methods and the control of biotin-DNA conjugate’s binding for evasion of similar misunderstanding by readers.

Additionally, please make the following changes:

Do not number the categories within the manuscript.  This is not in the style of the journal.

***Note:  Please return a document that contains both the text and graphics.***

To revise your manuscript, log into ACS Paragon Plus at http://paragonplus.acs.org/login and select "My Authoring Activity".  There you will find your manuscript title listed under "Revisions Requested by Editorial Office."  Your original files are available to you when you upload your revised manuscript.  If you are replacing files, please remove the old version of the file from the manuscript before uploading the new file.

When submitting your revised manuscript through ACS Paragon Plus, you will be able to respond to the comments made by the reviewer(s) in the text box provided or by attaching a file containing your detailed responses to all of the points raised by the reviewers.

If your revised manuscript is received more than 90 days from the date of this letter, it may be considered as a new submission and and sent out for additional review.

Thank you for your interest in Bioconjugate Chemistry and manuscript submission.

Sincerely,


Masayuki Yokoyama
Associate Editor
Bioconjugate Chemistry
Email:  Yokoyama-office@bioconj.acs.org

------------------------------------

Please click the link below to view the Bioconjugate Chemistry Author Guidelines:
http://pubs.acs.org/page/bcches/submission/index.html

Reviewer(s)' Comments to Author:

Reviewer: 1

Recommendation: It appears that publication in any form would be premature at this time.

Comments:

This manuscript describes the development of quantitative detection of single molecules using enhancement of Dye-labeled nanoparticles. The idea is interesting, but this detection may not be quantitative. The number of biotin-DNA bound to avidin-beads cannot be normally controlled. In DNA hybridization, all complementary single-stranded oligonucleotides cannot be hybridized. Thus, this fluorescence immunoassay does not seem to be a general procedure for quantitative detection. Thus, it is not recommended for publication.

Please rate the overall importance of this paper to the field of bioconjugate chemistry. (10 - High importance/1 - Low importance): 3


Reviewer: 2

Recommendation: Publish after major revisions noted.

Comments:

This paper describes a new methodology of signal amplification in single-molecule observations for highly sensitive immunoassays. The method is based on the in-situ preparation of antigen (IgG) / biotinylated antibody / streptavidin-coated magnetic nanobead / biotinylated double-stranded DNA / SYBR Green I conjugates on an epoxy-functionalized glass substrate. These conjugates are subject to epifluorescence microscopic observation with an electron multiplying CCD, affording the linear relationship between the number of magnetic beads and the concentration of antigen. Major and minor comments are as follows.

Major points:

1. Compare the sensitivity, photostability, cost-effectiveness, etc of the present method with those of the authors’ previous methods (ref 23, 27 and 30) in the Results & Discussion part.  
2. The experimental evidence for a 1:1 binding of a biotinylated antibody to a streptavidin-coated magnetic bead is not sufficient.   
3. The origin of the quenching at ratio over 0.25 in Figure 4 is unclear. I cannot understand the reason why non-intercalative binding of SYBR Green I to dsDNA induces the significant decrease in fluorescence intensity.
4. In the legend of Figure 6, “(A1) 50, (B1) 30, (C1) 10, (D1) 8, (E1) 5, (F1) 3” should be “(A1) 3, (B1) 5, (C1) 8, (D1) 10, (E1) 30, (F1) 50”. In addition, the meaning of red circles in (F1) should be given in this legend.

Minor points:

1. On page 8, line 3, describe the concentration of BT-Ab.
2. On page 8, line 14, add the information on the procedure for magnetic separation. The explanation on page 11, lines 6-9 should be moved to the Experimental Section.
3. On page 8, line 17, describe the concentration of BT-dsDNA.  
4. On page 10, line 1, describe the calculated distance between proteins.
5. On page 10, line 3, impossible -> possible
6. On page 10, line 11, the distance between two adjacent MNBs -> the diameter of the MNB (?)
7. On page 12, line 2, 10^15 / M -> 10^15 / M^-1
8. On page 12, line 5, describe the value offered by the manufacture’s instructions.
9. On page 14, line 1 from the bottom, SYBR Green I/BT-dsDNA/SA-MNB -> SA-MNB/BT-dsDNA/SYBR Green I
10. … are shown in Figure 6, -> … are shown in Figure 6. (page 15, line 7)
11. … a 6 by 6 pixel area, While … -> … a 6 by 6 pixel area. While … (page 15, line 15)
  

Please rate the overall importance of this paper to the field of bioconjugate chemistry. (10 - High importance/1 - Low importance): 6


Reviewer: 3

Recommendation: It appears that publication in any form would be premature at this time.

Comments:

This paper uses fluorescently labelled DNA attached to streptavidin-coated magnetic beads to detect the presence of a biotinylated antibody on a surface.  There's really no reason to use DNA, any fluorescently labelled biotinylated molecule would do fine.  Also, the antigen is non-specifically adsorbed to the surface; a second antibody would result in a true ELISA antibody sandwich assay.  Only one antigen is used;  the specificity of the antigen-Ab binding is not confirmed.  Recommendation:  reject and have the authors redo the work using a second surface antibody.

Please rate the overall importance of this paper to the field of bioconjugate chemistry. (10 - High importance/1 - Low importance): 2

-----------------------------------------------------------------------
FOR ASSISTANCE WITH YOUR MANUSCRIPT SUBMISSION PLEASE CONTACT:

ACS Publications Customer Services & Information (CSI)
Email: support@services.acs.org
Phone: 202-872-4357
Toll Free Phone: 800-227-9919 (USA/Canada only)
这是全部的审稿意见,大家帮忙看一下。
3楼2010-06-28 16:29:12
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

xuezhaoteng

金虫 (正式写手)

感觉第三个人对我很不利,第一个审稿人主编都貌似对他都不满,第二个审稿人的意见提了不少,但是我感觉不是很难回答,主要是第三个人的意见,虽然短,但是感觉不好回答,不知我的理解对吗?
4楼2010-06-28 16:32:24
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
普通表情 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[基金申请] 2026年叶企孙基金 +3 bud_bud 2026-08-27 6/300 2026-08-28 11:53 by bud_bud
[基金申请] 投票:  有多少人是今天查系统知道结果的? +16 爱看书的可乐 2026-08-26 18/900 2026-08-28 11:48 by winsaint
[基金申请] 基金系统什么内容也没有 30+4 winsaint 2026-08-27 9/450 2026-08-28 11:06 by maolC
[基金申请] 为什么资助数各大高校都创新高,自己申请怎么就这么难 +10 Kittylucky 2026-08-27 11/550 2026-08-28 10:45 by Kittylucky
[基金申请] 哪位高人中了,把查询到的截图贴出来让我看看,让我长长见识 +5 yuleib84 2026-08-26 6/300 2026-08-28 00:02 by yudaoqian88
[基金申请] 面上合作单位盖章 +5 ssyjh 2026-08-27 5/250 2026-08-27 20:50 by gdfollow
[教师之家] 导师吐槽:我怎么摊上了这么个极品研究生! +7 苏东坡二世 2026-08-23 7/350 2026-08-27 18:14 by 瞬息宇宙
[基金申请] 申请删除本帖 +6 lyz123lyz 2026-08-27 7/350 2026-08-27 17:31 by 宁静致远sy
[基金申请] 怎么看青基中了没有啊 +5 叶九微 2026-08-26 5/250 2026-08-27 10:35 by l_zh2008
[基金申请] 2026年的国家社科基金项目通讯评审的新规则与新动向、新挑战 +7 process2012 2026-08-23 10/500 2026-08-26 19:23 by hmhminy
[基金申请] 系统查不到 +10 董八千 2026-08-26 10/500 2026-08-26 16:30 by Equinoxhua
[基金申请] 2026年8月25日国自然放榜前突然收到列入评审专家邮件,有关系吗? +25 木水思豆 2026-08-25 28/1400 2026-08-26 14:53 by draco1987
[基金申请] 为什么国自然不能直接公布 +4 bjdxyxy 2026-08-26 4/200 2026-08-26 13:12 by qingmu1201
[基金申请] 国合里面能看到了 +7 一怀馨秋 2026-08-26 7/350 2026-08-26 11:23 by zhaosm1982
[基金申请] 国际合作可查了,中了面上 (EPI+1)(金币+50) +18 Ldrop2023 2026-08-26 18/900 2026-08-26 11:15 by cmrandy
[基金申请] 项目信息和经费信息在系统里都可以看到了 +6 wittyboy 2026-08-26 14/700 2026-08-26 10:55 by wittyboy
[基金申请] 国合可查了 +3 paperzjh 2026-08-26 3/150 2026-08-26 10:41 by LemmonTr
[基金申请] 某些机构,以效率低为荣,以效率低作为存在感 +9 yuleib84 2026-08-25 10/500 2026-08-25 17:14 by alexon
[基金申请] 建议基金发布提前给出明确的时间点 +13 kulium 2026-08-21 16/800 2026-08-24 16:27 by superceng
[教师之家] 跳槽后在研项目怎么办? +5 简单化xn 2026-08-22 10/500 2026-08-23 12:38 by 简单化xn
信息提示
请填处理意见